The European Union (EU) will ask the United States to allow the export of millions of doses of the corona virus vaccine produced by Astrogeneka. The request for cooperation is now unofficial Revealed Financial Times, Will be provided with the aim of controlling the effects of what is not provided in Europe as announced by the pharmaceutical company. “We hope to work with the United States to ensure that vaccines manufactured or packaged in the United States are fully respected for fulfilling the contractual obligations of vaccine manufacturers with the European Union,” a European Commission source said. Quote From Financial Times.
The commission’s chairman, Ursula van der Leyen, also called on US President Joe Biden on Friday to launch some cooperation against the epidemic. In addition to the readiness levels, the EU wants additional guarantees for access to the raw materials needed to produce vaccines, especially those based on ambassador RNA.
In recent months, the European Union has signed agreements to buy up to 400 million doses of AstraZeneca vaccine, and 2 billion doses are being purchased from other pharmaceutical companies. Although the vaccination campaign began in late December 2020, currently the rates of administration in European countries continue to be slow: 33 million doses have been administered and 11 million people have received the second dose. AstraZeneca had promised to deliver 90 million doses by the end of March, but announced a reduction of 65 to 70 percent in January and a 50 percent reduction in the second quarter.
In Italy, it was expected to deliver five million doses in the first quarter and 20 million doses in the second quarter. “These are quantities that can be imported from other countries and we are currently trying to improve our production chain with all the plants in the world,” he said. Explained In an interview with Lorenzo Vittam, CEO of AstraGeneca Italy recently ClassCnbc.
– read more: Suffering from vaccines is not worth it
As European Commission President Ursula van der Leyen said, without a sustainable supply, it would be very difficult to reach the goal of vaccinating 70 percent of the adult population by the end of the summer.
This week the European Commission and Italy blocked the export of the 250,000 dose of AstraZeneca vaccine imposed on Australia. The ship was intercepted due to a mechanism introduced by the European Union in late January to restrict exports for authorization purposes. 250 thousand blocked quantities were filled at the Cataland factory in Anacni, Frosinone province.
– read more: Italy has banned the export of 250,000 doses of AstraZeneca vaccine to Australia
Italian Ministry of Foreign Affairs Explained The choice of non-export approval was made for three reasons: the spread of the virus in Australia is limited and not as severe as in Europe, and the problems of the vaccine shortage persist in European countries, and finally in general, the vaccine that has so far been subject to EU countries requesting export approval compared to the quantities supplied to Italy.
The decision to block the ship was welcomed by other European countries. Oliver Vernon of the French Ministry of Health he said He understood the decision of the Italian government and explained that France could “do this”. German Government Spokesman Stephen Seibert, he said Exports will not be suspended if companies respect agreements with the EU.